IFNA1 and familial pancreatic carcinoma: Particularly, in the field of pancreatic cancer, a multicenter phase II trial (5-FU, cisplatin, and IFN-α in conjunction with radiation therapy) confirmed the efficacy of IFN-based chemoradiation for PDAC [67].